PATENT CLAIM ANALYSIS

Application Number: 16105268
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "649000"]

Abstract:
Amisulpride is used in the therapy of nausea, vomiting or retches. The therapy may utilize a novel injectable formulation, in unit dosage form, comprising less than 50 mg amisulpride.

Claim (Index 15):
The pharmaceutical composition of  claim 1 , wherein the pharmaceutical composition is formulated for transdermal administration.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 96.0
- Lexical Diversity: 1.17241
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14172194', '13559253', '13559168', '14812148', '15790481']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8440130821517117
- 35 USC 102 Novelty (BERT): 0.5555960828602623
- Combined Prediction Score: 0.8151713822225668
- Mean Citation Score: 425.5313560000001
- Max Citation Score: 430.3285
- Similarity Product: 329.5706502583623

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test